biopharmaceutical company.
Oxford BioMedica Plc (Oxford Biomedica) is a biopharmaceutical company involved in the development and commercialization of gene-based medicines.
What does Oxford Biomedica do?
A life saving cell and gene therapy group
We work across key viral vector delivery systems including adeno-associated virus (AAV) to provide innovative solutions to cell and gene therapy biotechnology and biopharma companies.
Share price forecast in GBX
The 7 analysts offering 12 month price targets for Oxford BioMedica plc have a median target of 1,110.00, with a high estimate of 2,400.00 and a low estimate of 360.00. The median estimate represents a 261.56% increase from the last price of 307.00.
The fall in revenues, combined with additional operational expenses related to the January 2022 acquisition of Homology Medicines to spearhead the establishment of the Oxford Biomedica Solutions division, pushed the group into losses.
Where is Oxford Biomedica based?
Oxfordshire, UK
Oxford Biomedica UK Limited (OXB) is based across several locations in Oxfordshire, UK. In early 2022, the Group established Oxford Biomedica Solutions, a new US based subsidiary AAV manufacturing and innovation business, based near Boston, US.
What are the benefits of Oxford?
Why Oxford Works: 10 Benefits to Studying at Oxford University
- You’re surrounded by some of the smartest people in the world.
- You get to work with them and socialise with them.
- You will meet a huge variety of people.
- Top employers will court you.
- You can get noticed, even as an undergraduate.
- You can’t rest on your laurels.
You can buy or sell Oxford Biomedica plc shares through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account.
Oxford Biomedica has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Is Oxford Nanopore a good investment?
On a 12 month basis, the Oxford Nanopore Technologies share price has seen an absolute move of %. On a relative basis – which take into account the movement of the wider market – the shares have moved by % over the past year and by -55.1% over the past six months.
What is the best biomedical stock?
Biotech Hasn’t Been This Blazing Hot Since Early 2021 — Here Are The Top 5
- Catalyst Pharmaceuticals (CPRX)
- Genmab (GMAB)
- Harmony Biosciences (HRMY)
- Vertex Pharmaceuticals (VRTX)
- Neurocrine Biosciences (NBIX)
Is BPL a good buy?
The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of BPL Ltd is likely to Rise-somewhat in the short term.
Is stem still a buy?
Stem has received a consensus rating of Buy. The company’s average rating score is 2.88, and is based on 7 buy ratings, 1 hold rating, and no sell ratings.
Is Oxford Nanopore profitable?
In the last twelve months, Oxford Nanopore Technologies increased its revenue by 58%. That’s a strong result which is better than most other loss making companies.
How many employees does Oxford Biomedica have?
Equality, Inclusion and Diversity
| Male | Total | |
|---|---|---|
| Board including non-Executive Directors | 7 | 10 |
| Senior managers and direct reports | 24 | 48 |
| All other employees | 350 | 757 |
| Total | 381 | 815 |
Does Oxford Biomedica pay dividends?
Sign up for Oxford Biomedica and we’ll email you the dividend information when they declare. Add Oxford Biomedica to receive free notifications when they declare their dividends.
Dividend Summary.
| Year | Amount | Change |
|---|---|---|
| 2016 | 0.0p | 0% |
| 2017 | 0.0p | 0% |
| 2018 | 0.0p | 0% |
| 2019 | 0.0p | 0% |
Intraday Oxford Biomedica Share Chart
| Oxford Biomedica Share Price | |
|---|---|
| Price | 324.50 |
| Bid | 326.00 |
| Ask | 328.00 |
| Change | 17.50 (5.70%) |
How does the Oxford system work?
Oxford’s colleges are independent and self-governing, and relate to the University in a federal system like that of the United States. The University has 44 colleges. This includes five permanent private halls (PPHs), which were founded by various Christian denominations and still retain their religious character.
Is it hard to get into Oxford?
The University of Oxford is a highly selective institution, with an acceptance rate of approximately 17%. However, the acceptance rate for international students applying to the school is lower: around 9% only. Still, nearly half of the students attending Oxford University are from outside the UK.
What is the acceptance rate for Oxford?
Oxford Nanopore is a public company, headquartered at the Oxford Science Park outside Oxford, UK, with satellite offices in Cambridge (UK), New York, Cambridge, San Francisco (US), Singapore, Shanghai, Beijing, and a broader commercial presence that includes Japan, Germany, France and India.
Is Oxford Nanopore a public company?
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Windlas Biotech Ltd is likely to Fall in the short term.
Is Windlas biotech a good buy?
3 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Meggitt in the last year. There are currently 2 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should “hold” MGGT shares.